{"id":"W2126532431","doi":"10.3324/haematol.2014.119545","title":"A pooled analysis of overall survival in COMFORT-I and COMFORT-II, 2 randomized phase III trials of ruxolitinib for the treatment of myelofibrosis","year":2015,"lang":"en","type":"article","venue":"Haematologica","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":253,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; University of Texas MD Anderson Cancer Center","keywords":"Ruxolitinib; Medicine; Hazard ratio; Internal medicine; Myelofibrosis; Placebo; Survival analysis; Confidence interval; Crossover study; Proportional hazards model; Surgery; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002040311,0.0002578518,0.005087342,0.0002908129,0.00005053233,0.000006427245,0.00007583545,0.0001155578,0.0001232198],"category_scores_gemma":[0.001035574,0.0001260024,0.0008786019,0.000353648,0.0003031916,0.00003005739,0.00003119223,0.00004057908,1.893991e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000529614,"about_ca_system_score_gemma":0.0001099153,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006229859,"about_ca_topic_score_gemma":0.0001942019,"domain_scores_codex":[0.9970554,0.0004593081,0.001688351,0.0002775105,0.0002979438,0.0002215457],"domain_scores_gemma":[0.9932458,0.005097935,0.0009632641,0.0003499198,0.0002207142,0.0001223371],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6767585,0.02320636,0.1819709,0.0005704511,0.05021477,0.00008517459,0.01189435,0.00032686,0.00140334,0.04175377,0.000591236,0.0112243],"study_design_scores_gemma":[0.8975375,0.01012181,0.01262134,0.0002359703,0.03451324,0.00002132586,0.001360991,0.007119356,0.03383325,0.001330959,0.001043346,0.0002609129],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9918848,0.002806047,0.0003015029,0.0005937257,0.00005054502,0.003573129,0.0004096933,0.00001129509,0.0003692901],"genre_scores_gemma":[0.9960652,0.001676832,0.001125296,0.00004673903,0.00001619307,0.0008026774,0.0001818054,0.0000100317,0.000075212],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.220779,"threshold_uncertainty_score":0.5138227,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1259945300572344,"score_gpt":0.3900717844310114,"score_spread":0.2640772543737769,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}